Drug Trial Radar · NCT02470091
Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma
Last checked: Nov 19, 2026Latest source record: Jan 22, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
56
Actual
Start
Nov 21, 2015
Primary completion
Dec 31, 2019
Study completion Dec 31, 2023
Sponsor
- Lead sponsor
- Children's Oncology GroupResearch network
- Sponsor type
- Research network
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Jun 12, 2015
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 11 years, up to 49 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase II trial studies how well denosumab works in treating patients with osteosarcoma that has come back (recurrent) or does not respond to treatment (refractory). Immunotherapy with monoclonal antibodies, such as denosumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.
Conditions
- Metastatic Osteosarcoma
- Recurrent Osteosarcoma
- Refractory Osteosarcoma
- Stage IV Osteosarcoma AJCC v7
- Stage IVA Osteosarcoma AJCC v7
- Stage IVB Osteosarcoma AJCC v7
Interventions
DenosumabBiological
Given SC
Laboratory Biomarker AnalysisOther
Correlative studies
Pharmacological StudyOther
Correlative studies
Primary outcomes
What the sponsor says the trial is designed to measure.
- Disease Control Rate (Cohort I)Time frame: At 4 months
- Response Evaluation Criteria in Solid Tumors (RECIST) Response (Complete Response [CR] or Partial Response [PR] vs Not CR or PR) (Cohort I)Time frame: At 4 months
- Disease Control Rate (Cohort II)Time frame: At 12 months
Locations
141 sites in 3 countries. Site status is shown where the registry gives one.
Children's Hospital of Alabama
Birmingham, Alabama
Phoenix Childrens Hospital
Phoenix, Arizona
Banner University Medical Center - Tucson
Tucson, Arizona
Arkansas Children's Hospital
Little Rock, Arkansas
Kaiser Permanente-Anaheim
Anaheim, California
Kaiser Permanente-Bellflower
Bellflower, California
Kaiser Permanente Downey Medical Center
Downey, California
Kaiser Permanente-Fontana
Fontana, California
Loma Linda University Medical Center
Loma Linda, California
Children's Hospital Los Angeles
Los Angeles, California
Kaiser Permanente Los Angeles Medical Center
Los Angeles, California
Valley Children's Hospital
Madera, California
UCSF Benioff Children's Hospital Oakland
Oakland, California
Children's Hospital of Orange County
Orange, California
University of California Davis Comprehensive Cancer Center
Sacramento, California
Kaiser Permanente-San Diego Zion
San Diego, California
Rady Children's Hospital - San Diego
San Diego, California
UCSF Medical Center-Mission Bay
San Francisco, California
Children's Hospital Colorado
Aurora, Colorado
Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center
Denver, Colorado
Connecticut Children's Medical Center
Hartford, Connecticut
Alfred I duPont Hospital for Children
Wilmington, Delaware
Children's National Medical Center
Washington D.C., District of Columbia
University of Florida Health Science Center - Gainesville
Gainesville, Florida
Nemours Children's Clinic-Jacksonville
Jacksonville, Florida
University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida
Nicklaus Children's Hospital
Miami, Florida
AdventHealth Orlando
Orlando, Florida
Nemours Children's Hospital
Orlando, Florida
Johns Hopkins All Children's Hospital
St. Petersburg, Florida
Saint Joseph's Hospital/Children's Hospital-Tampa
Tampa, Florida
Saint Mary's Hospital
West Palm Beach, Florida
Children's Healthcare of Atlanta - Egleston
Atlanta, Georgia
Kapiolani Medical Center for Women and Children
Honolulu, Hawaii
Saint Luke's Cancer Institute - Boise
Boise, Idaho
Centralia Oncology Clinic
Centralia, Illinois
Lurie Children's Hospital-Chicago
Chicago, Illinois
University of Illinois
Chicago, Illinois
University of Chicago Comprehensive Cancer Center
Chicago, Illinois
Carle at The Riverfront
Danville, Illinois
Showing 40 of 141 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.